Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute leukemia in adults

M Minden1, K Imrie, A Keating

  • 1Division of Hematology, University of Toronto, Ontario, Canada.

Current Opinion in Hematology
|July 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inflammatory signals from fatty bone marrow support DNMT3A driven clonal hematopoiesis.

Nature communications·2023
Same author

Successful treatment of gastrointestinal mucormycosis in an adult with acute leukemia: case report and literature review.

Current oncology (Toronto, Ont.)·2017
Same author

Rituximab in Lymphoma and Chronic Lymphocytic Leukaemia: A Practice Guideline.

Clinical oncology (Royal College of Radiologists (Great Britain))·2016
Same author

T-Cell Blast Crisis in Chronic Myeloid Leukemia.

Leukemia & lymphoma·2016
Same author

Highlights of the Fifth International Symposium on Autologous Bone Marrow Transplantation Omaha, Nebraska, August 23-25, 1990.

Leukemia & lymphoma·2016
Same author

Highlights of the 19th Annual Meeting of the International Society for Experimental Hematology (ISEH) Held in Seattle, Washington, USA, August 26-30, 1990.

Leukemia & lymphoma·2016
Same journal

Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

Current opinion in hematology·2026
Same journal

Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

Current opinion in hematology·2026
Same journal

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Current opinion in hematology·2026
Same journal

From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

Current opinion in hematology·2026
Same journal

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same journal

The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

Current opinion in hematology·2026
See all related articles

New strategies for adult acute leukemia focus on understanding leukemic cell biology and drug resistance. Research explores dose intensification, growth factors, and genetic markers for tailored treatments.

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Acute leukemia treatment is evolving with new therapeutic approaches.
  • Understanding leukemic cell biology is crucial for improving patient outcomes.
  • Drug resistance mechanisms significantly impact treatment efficacy.

Purpose of the Study:

  • To review emerging trends in adult acute leukemia treatment and investigation.
  • To highlight the importance of leukemic cell biology in overcoming treatment failures.
  • To discuss advancements in understanding drug resistance and prognostic factors.

Main Methods:

  • Review of recent studies on chemotherapy, dose intensification, and bone marrow transplantation.
  • Analysis of research on drug resistance mechanisms (proximal and distal).

Related Experiment Videos

  • Examination of genetic alterations and their prognostic implications.
  • Evaluation of novel growth factors (thrombopoietin, Flt3 ligand) and inhibitors (interleukin-10).

    • Main Results:

    • Dose intensification and intensive chemotherapy with growth factors show promise in specific patient groups.
    • Autologous bone marrow transplantation is being studied for older patients.
    • New insights into proximal and distal drug resistance mechanisms have been identified.
    • Cytogenetic and molecular genetic changes correlate with prognosis.
    • Growth factors and inhibitors influencing leukemic cell growth are under investigation.

    Conclusions:

    • Tailoring therapies based on leukemic cell biology and individual patient needs is essential.
    • Understanding drug resistance mechanisms can guide the development of more effective treatments.
    • Genetic profiling aids in identifying patients with different therapeutic requirements.
    • Further research into growth factors and inhibitors may lead to targeted therapies.